Anrose Pharma Limited
About Anrose Pharma Limited
Data last updated:
Anrose Pharma Limited was a public limited company based in Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 July 2008.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2008PLC180945.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was formerly known as Sarabhai Labs Limited. It was led by directors including Ankit Agarwal and Rohan Agarwal.
Its last annual general meeting (AGM) was held on 26 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at 1704 Iind Floor Bhagirath Palace, Delhi, India – 110006.
Court records list 4 cases involving the company, including 2 filed by the company and 2 filed against it.
Company details
Contact details
Anrose Pharma Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1704 Iind Floor Bhagirath Palace, Delhi, India – 110006
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Anrose Pharma Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Anrose Pharma Limited
FY 2018 filings availableFinancial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Anrose Pharma Limited, buy the company report.
Board of directors of Anrose Pharma Limited
Anrose Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aarohi Agarwal Also directs: Novacross Health Care Limited, Sunmax Pharma Limited | Additional Director | 14 Nov 2018 | 7 Years 11 Months | As last reported |
| Ankit Agarwal Also directs: Novacross Health Care Limited, Sunmax Pharma Limited, Actinova Private Limited and 1 more | Director | 16 Jul 2008 | 18 Years 3 Months | As last reported |
| Rohan Agarwal | Director | 16 Jul 2008 | 18 Years 3 Months | As last reported |
Auditor
Anrose Pharma Limited is audited by ALOK HIRA & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ALOK HIRA & ASSOCIATES | FY 2018 | 023061N |
Shareholding
The shareholding of Anrose Pharma Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Anrose Pharma Limited, buy the company report.
Legal cases
Anrose Pharma Limited has 4 court cases on record: 2 filed by Anrose Pharma, 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 2 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Court case (Contempt Petition) | Filed against the company by M/S. Laborate Pharmaceuticals India Ltd. | Disposed |
| District court, Central, Delhi | Commercial suit | Filed against the company by Laborate Pharmaceuticals India Ltd | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Ms H.D.Pharmachem | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Ms H.D. Pharmachem. | Disposed |
To see the full case history of Anrose Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anrose Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Anrose Pharma Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Anrose Pharma Limited has 4 board changes on record since 2008: 3 appointments and 1 cessation. The latest: Aarohi Agarwal was appointed as Additional Director on 14 Nov 2018.
Frequently asked questions
Anrose Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Anrose Pharma was a public limited company based in Delhi, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 16 July 2008 and is registered under CIN U51397DL2008PLC180945. The company has been struck off by the Registrar of Companies and is no longer operational.
Anrose Pharma had 3 directors:
- Aarohi Agarwal - Additional Director
- Ankit Agarwal - Director
- Rohan Agarwal - Director
The CIN (Corporate Identification Number) of Anrose Pharma is U51397DL2008PLC180945. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Anrose Pharma is at 1704 Iind Floor Bhagirath Palace, Delhi, India – 110006.
Anrose Pharma was incorporated on 16 July 2008. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Anrose Pharma on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 26 September 2018. Year-wise statements from 2015 are in the company report.
Anrose Pharma operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
Anrose Pharma has 4 court cases on record: 2 filed by the company and 2 filed against it.
Aarohi Agarwal was appointed as Additional Director on 14 Nov 2018. Poonam Agarwal ceased to be Director on 14 Nov 2018. Ankit Agarwal was appointed as Director on 16 Jul 2008. Anrose Pharma has 4 board changes on record in total.